Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA pseudogenes are non-functional copies of the U6 snRNA gene that have accumulated mutations and lost their original splicing function. However, recent research has revealed that many pseudogenes, including U6 pseudogenes, are not simply "junk DNA" but can have regulatory functions[2]. U6 snRNA itself is a highly conserved component of the spliceosome that catalyzes intron removal from pre-mRNA[1]. The authentic U6 snRNA is the most evolutionarily conserved of all spliceosomal snRNAs, with vertebrate genomes containing multiple copies and pseudogenes, suggesting its critical importance[1]. U6 pseudogenes can be transcribed and processed into small interfering RNAs that regulate their parent coding genes through RNA interference pathways[2]. Some pseudogenes also function as competitive endogenous RNAs or "microRNA decoys," binding microRNAs and thereby protecting their parent genes from microRNA-mediated repression[2]. The specific pseudogene "RNU6-583P" mentioned in the query does not appear in standard databases, though RNU6-83P exists as a documented U6 snRNA pseudogene[4]. One characterized human U6 snRNA pseudogene contains novel structural features including direct repeats of genuine U6 RNA sequences[5]. The target designation "RNU6-583P" appears to be incorrect or non-standard, as it does not match known nomenclature for documented U6 snRNA pseudogenes in human databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA U6 small nuclear pseudogene (RNU6 pseudogene).